| Drug Name |
Gabapentin enacarbil |
| Drug ID |
BADD_D00982 |
| Description |
Gabapentin enacarbil is marketed under the name Horizant. It is a prodrug of gabapentin, and indicated in adults for the treatment of Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN). |
| Indications and Usage |
For the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN). |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB08872
|
| KEGG ID |
D09539
|
| MeSH ID |
C493250
|
| PubChem ID |
9883933
|
| TTD Drug ID |
D05KBU
|
| NDC Product Code |
49187-0710; 70966-0011; 53451-0103; 53451-0101; 66039-945 |
| UNII |
75OCL1SPBQ
|
| Synonyms |
1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid | gabapentin enacarbil | XP 12464 | XP12464 | XP-12464 | XP 10569 | XP10569 | XP-10569 | XP 11239 | XP11239 | XP-11239 | XP 13512 | XP13512 | XP-13512 | XP 11084 | XP11084 | XP-11084 |
